HR011408

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HR011408, covering 2024-05-21 to 2024-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of HR011408 and NovoRapid® in Subjects With Diabetics [Phase 1]